PHILLIP MD ET AL FROST Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PHILLIP MD ET AL FROST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILLIP MD ET AL FROST. PHILLIP MD ET AL FROST is 10% Owner in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and 10% Owner in TRANSENTERIX INC. ($TRXC) and Director in TRANSENTERIX INC. ($TRXC) and CEO & Chairman in Opko Health, Inc. ($EXEG) and Director in CONTINUCARE CORP ($CNU) and 10% Owner in Protalix BioTherapeutics, Inc. ($PLX) and Director in LADENBURG THALMANN FINANCIAL SERVICES INC ($LTS) and Director in PROLOR Biotech, Inc. ($PBTH).
Latest Insider Trading Transactions of PHILLIP MD ET AL FROST
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TRXC, CNU, LTS, NIMU, EXEG, PBTH, PLX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 17 2013 | PBTH | PROLOR Biotech, In ... | FROST PHILLIP MD ET AL | Director | Buy | P | 6.39 | 3,000 | 19,156 | 9,752,549 | 9.7 M to 9.8 M (+0.03 %) |
May 16 2013 | PBTH | PROLOR Biotech, In ... | FROST PHILLIP MD ET AL | Director | Buy | P | 6.50 | 6,600 | 42,924 | 9,749,549 | 9.7 M to 9.7 M (+0.07 %) |
May 02 2013 | PBTH | PROLOR Biotech, In ... | FROST PHILLIP MD ET AL | Director | Buy | P | 6.25 | 10,000 | 62,510 | 9,651,749 | 9.6 M to 9.7 M (+0.10 %) |
Oct 06 2011 | PBTH | PROLOR Biotech, In ... | FROST PHILLIP MD ET AL | Director | Buy | P | 3.81 | 10,000 | 38,131 | 11,304,935 | 11.3 M to 11.3 M (+0.09 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.22 | 2,000 | 4,440 | 96,998,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.21 | 2,000 | 4,420 | 96,996,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.19 | 1,000 | 2,190 | 96,994,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.18 | 1,000 | 2,180 | 96,993,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.16 | 1,000 | 2,160 | 96,992,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.13 | 1,000 | 2,130 | 96,991,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.09 | 1,000 | 2,090 | 96,990,381 | 97 M to 97 M (0.00 %) |
Nov 02 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.06 | 1,000 | 2,060 | 96,989,381 | 97 M to 97 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.23 | 100 | 223 | 96,948,381 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.22 | 800 | 1,776 | 96,948,281 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.21 | 581 | 1,284 | 96,947,481 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.18 | 2,901 | 6,324 | 96,946,900 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.17 | 99 | 215 | 96,943,999 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.16 | 1,700 | 3,672 | 96,943,900 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.15 | 1,300 | 2,795 | 96,942,200 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.14 | 519 | 1,111 | 96,940,900 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.13 | 1,000 | 2,130 | 96,940,381 | 96.9 M to 96.9 M (0.00 %) |
Oct 28 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.10 | 1,000 | 2,100 | 96,939,381 | 96.9 M to 96.9 M (0.00 %) |
Dec 29 2009 | NIMU | NON INVASIVE MONIT ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 0.29 | 100,000 | 29,000 | 11,500,000 | 11.4 M to 11.5 M (+0.88 %) |
May 18 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.28 | 1,900 | 2,432 | 95,652,547 | 95.7 M to 95.7 M (0.00 %) |
May 18 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.25 | 1,000 | 1,250 | 95,650,647 | 95.6 M to 95.7 M (0.00 %) |
May 18 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.24 | 700 | 868 | 95,649,647 | 95.6 M to 95.6 M (0.00 %) |
May 18 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.23 | 400 | 492 | 95,648,947 | 95.6 M to 95.6 M (0.00 %) |
May 18 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.00 | 166,600 | 166,600 | 95,648,547 | 95.5 M to 95.6 M (+0.17 %) |
May 14 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.08 | 1,000 | 1,080 | 95,481,947 | 95.5 M to 95.5 M (0.00 %) |
May 14 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.07 | 3,000 | 3,210 | 95,480,947 | 95.5 M to 95.5 M (0.00 %) |
May 13 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.15 | 1,300 | 1,495 | 95,477,947 | 95.5 M to 95.5 M (0.00 %) |
May 13 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.14 | 2,500 | 2,850 | 95,476,647 | 95.5 M to 95.5 M (0.00 %) |
May 13 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.13 | 3,700 | 4,181 | 95,474,147 | 95.5 M to 95.5 M (0.00 %) |
May 12 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.15 | 2,500 | 2,875 | 95,470,447 | 95.5 M to 95.5 M (0.00 %) |
May 12 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.14 | 300 | 342 | 95,467,947 | 95.5 M to 95.5 M (0.00 %) |
May 12 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.13 | 1,150 | 1,300 | 95,467,647 | 95.5 M to 95.5 M (0.00 %) |
May 12 2009 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.12 | 50 | 56 | 95,466,497 | 95.5 M to 95.5 M (0.00 %) |
Mar 11 2009 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 0.90 | 3,500 | 3,150 | 4,115,265 | 4.1 M to 4.1 M (+0.09 %) |
Feb 11 2009 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 0.80 | 200 | 160 | 4,111,765 | 4.1 M to 4.1 M (0.00 %) |
Feb 03 2009 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 0.75 | 1,000 | 750 | 4,111,565 | 4.1 M to 4.1 M (+0.02 %) |
Jan 29 2009 | NIMU | NON INVASIVE MONIT ... | FROST PHILLIP MD ET AL | 10% Owner | Option Exercise | P | 0.00 | 700 | 0 | 1,267 | |
Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.66 | 1,000 | 1,660 | 9,781,273 | 9.8 M to 9.8 M (+0.01 %) |
Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.64 | 2,500 | 4,100 | 9,780,273 | 9.8 M to 9.8 M (+0.03 %) |
Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.63 | 600 | 978 | 9,777,773 | 9.8 M to 9.8 M (+0.01 %) |
Oct 14 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 1.62 | 900 | 1,458 | 9,777,173 | 9.8 M to 9.8 M (+0.01 %) |
Dec 04 2008 | NIMU | NON INVASIVE MONIT ... | FROST PHILLIP MD ET AL | 10% Owner | Option Exercise | P | 0.00 | 137 | 0 | 567 | |
Dec 17 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 1.65 | 345,044 | 569,323 | 24,771,604 | 24.4 M to 24.8 M (+1.41 %) |
May 29 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.15 | 60,000 | 129,000 | 4,110,565 | 4.1 M to 4.1 M (+1.48 %) |
Apr 08 2008 | NIMU | NON INVASIVE MONIT ... | FROST PHILLIP MD ET AL | 10% Owner | Option Exercise | P | 0.00 | 430 | 0 | 430 | |
Jun 12 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 1.90 | 101,072 | 192,037 | 24,426,560 | 24.3 M to 24.4 M (+0.42 %) |
Mar 19 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.40 | 285 | 969 | 4,050,565 | 4.1 M to 4.1 M (+0.01 %) |
Mar 19 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.30 | 1,000 | 3,300 | 4,050,280 | 4 M to 4.1 M (+0.02 %) |
Mar 19 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.20 | 2,215 | 7,088 | 4,049,280 | 4 M to 4 M (+0.05 %) |
Mar 19 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.00 | 500 | 1,500 | 4,047,065 | 4 M to 4 M (+0.01 %) |
Mar 14 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.00 | 15,000 | 45,000 | 4,046,565 | 4 M to 4 M (+0.37 %) |
Mar 11 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.49 | 500 | 1,745 | 4,031,565 | 4 M to 4 M (+0.01 %) |
Mar 11 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.50 | 1,000 | 3,500 | 4,031,065 | 4 M to 4 M (+0.02 %) |
Feb 25 2008 | TRXC | TRANSENTERIX INC. | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 3.50 | 2,000 | 7,000 | 4,030,065 | 4 M to 4 M (+0.05 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.94 | 2,500 | 7,350 | 9,776,273 | 9.8 M to 9.8 M (+0.03 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.92 | 1,000 | 2,920 | 9,773,773 | 9.8 M to 9.8 M (+0.01 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.91 | 3,000 | 8,730 | 9,772,773 | 9.8 M to 9.8 M (+0.03 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.90 | 700 | 2,030 | 9,769,773 | 9.8 M to 9.8 M (+0.01 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.89 | 800 | 2,312 | 9,769,073 | 9.8 M to 9.8 M (+0.01 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.87 | 1,400 | 4,018 | 9,768,273 | 9.8 M to 9.8 M (+0.01 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.85 | 300 | 855 | 9,766,873 | 9.8 M to 9.8 M (0.00 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.84 | 100 | 284 | 9,766,573 | 9.8 M to 9.8 M (0.00 %) |
Mar 12 2008 | PLX | Protalix BioTherap ... | FROST PHILLIP MD ET AL | 10% Owner | Buy | P | 2.83 | 200 | 566 | 9,766,473 | 9.8 M to 9.8 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.89 | 1,800 | 5,202 | 47,904,157 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.87 | 1,100 | 3,157 | 47,902,357 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.83 | 1,000 | 2,830 | 47,901,257 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.82 | 100 | 282 | 47,900,257 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.79 | 1,000 | 2,790 | 47,900,157 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.75 | 3,000 | 8,250 | 47,899,157 | 47.9 M to 47.9 M (+0.01 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.85 | 1,500 | 4,275 | 47,896,157 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.82 | 900 | 2,538 | 47,894,657 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.81 | 1,500 | 4,215 | 47,893,757 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.80 | 1,500 | 4,200 | 47,892,257 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.78 | 2,300 | 6,394 | 47,890,757 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.77 | 100 | 277 | 47,888,457 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.76 | 1,200 | 3,312 | 47,888,357 | 47.9 M to 47.9 M (0.00 %) |
Jan 03 2008 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.75 | 1,000 | 2,750 | 47,887,157 | 47.9 M to 47.9 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.17 | 700 | 1,519 | 24,325,488 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.16 | 100 | 216 | 24,324,788 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.15 | 2,900 | 6,235 | 24,324,688 | 24.3 M to 24.3 M (+0.01 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.14 | 200 | 428 | 24,321,788 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.13 | 100 | 213 | 24,321,588 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.12 | 1,000 | 2,120 | 24,321,488 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.10 | 400 | 840 | 24,320,488 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.09 | 370 | 773 | 24,320,088 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.05 | 2,500 | 5,125 | 24,319,718 | 24.3 M to 24.3 M (+0.01 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.04 | 100 | 204 | 24,317,218 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.03 | 1,000 | 2,030 | 24,317,118 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.02 | 430 | 869 | 24,316,118 | 24.3 M to 24.3 M (0.00 %) |
Mar 24 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.00 | 200 | 400 | 24,315,688 | 24.3 M to 24.3 M (0.00 %) |
Feb 22 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.24 | 900 | 2,016 | 24,315,488 | 24.3 M to 24.3 M (0.00 %) |
Feb 22 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.23 | 100 | 223 | 24,314,588 | 24.3 M to 24.3 M (0.00 %) |
Feb 22 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.22 | 900 | 1,998 | 24,314,488 | 24.3 M to 24.3 M (0.00 %) |
Feb 22 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.20 | 2,100 | 4,620 | 24,313,588 | 24.3 M to 24.3 M (+0.01 %) |
Feb 22 2008 | CNU | CONTINUCARE CORP | FROST PHILLIP MD ET AL | Director | Buy | P | 2.19 | 1,000 | 2,190 | 24,311,488 | 24.3 M to 24.3 M (0.00 %) |
Dec 28 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.00 | 2,500 | 7,500 | 47,886,157 | 47.9 M to 47.9 M (+0.01 %) |
Dec 28 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.99 | 500 | 1,495 | 47,883,657 | 47.9 M to 47.9 M (0.00 %) |
Dec 28 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.10 | 2,800 | 8,680 | 47,883,157 | 47.9 M to 47.9 M (+0.01 %) |
Dec 28 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.09 | 400 | 1,236 | 47,880,357 | 47.9 M to 47.9 M (0.00 %) |
Dec 28 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.06 | 1,800 | 5,508 | 47,879,957 | 47.9 M to 47.9 M (0.00 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.05 | 1,700 | 5,185 | 47,878,157 | 47.9 M to 47.9 M (0.00 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.04 | 300 | 912 | 47,876,457 | 47.9 M to 47.9 M (0.00 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 400 | 1,212 | 47,876,157 | 47.9 M to 47.9 M (0.00 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.02 | 1,200 | 3,624 | 47,875,757 | 47.9 M to 47.9 M (0.00 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.00 | 5,400 | 16,200 | 47,874,557 | 47.9 M to 47.9 M (+0.01 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.99 | 100 | 299 | 47,869,157 | 47.9 M to 47.9 M (0.00 %) |
Dec 20 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.97 | 900 | 2,673 | 47,869,057 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.15 | 1,000 | 3,150 | 47,868,157 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.07 | 100 | 307 | 47,867,157 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.06 | 100 | 306 | 47,867,057 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.10 | 100 | 310 | 47,866,957 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.14 | 100 | 314 | 47,866,857 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 400 | 1,336 | 47,866,757 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.33 | 2,500 | 8,325 | 47,866,357 | 47.9 M to 47.9 M (+0.01 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 1,000 | 3,310 | 47,863,857 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 1,400 | 4,620 | 47,862,857 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 900 | 2,961 | 47,861,457 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 500 | 1,640 | 47,860,557 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 1,700 | 5,559 | 47,860,057 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 300 | 975 | 47,858,357 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 1,300 | 4,186 | 47,858,057 | 47.9 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 3,400 | 10,778 | 47,856,757 | 47.9 M to 47.9 M (+0.01 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.16 | 2,400 | 7,584 | 47,853,357 | 47.9 M to 47.9 M (+0.01 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.15 | 1,700 | 5,355 | 47,850,957 | 47.8 M to 47.9 M (0.00 %) |
Dec 17 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.13 | 2,500 | 7,825 | 47,849,257 | 47.8 M to 47.8 M (+0.01 %) |
Dec 10 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 500 | 1,660 | 47,846,757 | 47.8 M to 47.8 M (0.00 %) |
Dec 10 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 1,000 | 3,250 | 47,846,257 | 47.8 M to 47.8 M (0.00 %) |
Dec 10 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.23 | 2,400 | 7,752 | 47,845,257 | 47.8 M to 47.8 M (+0.01 %) |
Dec 10 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 1,100 | 3,542 | 47,842,857 | 47.8 M to 47.8 M (0.00 %) |
Dec 10 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 6,000 | 19,500 | 47,841,757 | 47.8 M to 47.8 M (+0.01 %) |
Dec 10 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 4,000 | 12,880 | 47,835,757 | 47.8 M to 47.8 M (+0.01 %) |
Oct 18 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 4.17 | 600 | 2,502 | 40,979,853 | 41 M to 41 M (0.00 %) |
Oct 18 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 4.15 | 400 | 1,660 | 40,979,253 | 41 M to 41 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.04 | 500 | 1,520 | 47,831,757 | 47.8 M to 47.8 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.03 | 1,600 | 4,848 | 47,831,257 | 47.8 M to 47.8 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.02 | 4,200 | 12,684 | 47,829,657 | 47.8 M to 47.8 M (+0.01 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.01 | 3,000 | 9,030 | 47,825,457 | 47.8 M to 47.8 M (+0.01 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.00 | 16,900 | 50,700 | 47,822,457 | 47.8 M to 47.8 M (+0.04 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.99 | 200 | 598 | 47,805,557 | 47.8 M to 47.8 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.96 | 2,000 | 5,920 | 47,805,357 | 47.8 M to 47.8 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.95 | 1,000 | 2,950 | 47,803,357 | 47.8 M to 47.8 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.86 | 1,200 | 3,432 | 47,802,357 | 47.8 M to 47.8 M (0.00 %) |
Dec 06 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 1.84 | 6,766,304 | 12,449,999 | 47,801,157 | 41 M to 47.8 M (+16.49 %) |
Nov 14 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.85 | 1,000 | 3,850 | 41,024,853 | 41 M to 41 M (0.00 %) |
Nov 14 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.78 | 1,600 | 6,048 | 41,023,853 | 41 M to 41 M (0.00 %) |
Nov 14 2007 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.75 | 8,900 | 33,375 | 41,022,253 | 41 M to 41 M (+0.02 %) |